OC-01

Oyster Point Pharma Inks Deal with Ji Xing for Dry Eye Disease Therapies
BioSpace
Sun, 08/8/21 - 12:00 am
Oyster Point Pharma
Ji Xing Pharmaceuticals
OC-01
OC-02
dry eye disease
China
FDA Accepts NDA for Oyster Point’s Dry Eye Therapy OC-01
BioSpace
Tue, 03/2/21 - 11:56 pm
Oyster Point
OC-01
dry eye disease
FDA
Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray
Endpoints
Mon, 05/11/20 - 10:36 am
Oyster Point Pharma
dry eye disease
OC-01
Allergan
Restasis
Shire
Xiidra
Oyster Point Pharma Files for $85 Million IPO
CP Wire
Mon, 10/7/19 - 10:57 am
Oyster Point Pharma
dry eye disease
OC-01
IPOs
Oyster Point Pharma Files for $85 Million IPO
Mon, 10/7/19 - 10:09 am
Oyster Point Pharma
dry eye disease
OC-01
IPOs
Oyster Point raises $93M series B to bring dry eye nasal spray to FDA
BioCentury
Tue, 02/26/19 - 09:38 am
Oyster Point
dry eye disease
OC-01
OC-02
Oyster Point's OC-01 dry eye nasal spray meets in Phase IIb
BioCentury
Wed, 10/24/18 - 10:16 am
Oyster Point
dry eye disease
OC-01
clinical trials